Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill Intensive Care Unit patients

International Journal of Antimicrobial Agents

Volumn 38, Issue 4, 2011, Pages 296-300

  Dong, Haiyan ^a   Wang, Xue ^a   Dong, Yalin ^a   Lei, Jin'E ^a   Li, Hao ^a   You, Haisheng ^a   Wang, Maoyi ^a   Xing, Jianfeng ^a   Sun, Jinyao ^a   Zhu, Huifang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Gram positive bacteria; Intensive Care Unit (ICU); Linezolid; Pharmacokinetic pharmacodynamic (PK PD); Severely ill patients

Indexed keywords

LINEZOLID;

ADULT; AGED; ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; CHINESE; CLINICAL ARTICLE; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INTERMITTENT THERAPY; DRUG TREATMENT FAILURE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE INFECTION; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LIVER FUNCTION; MALE; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; STAPHYLOCOCCUS;

ACETAMIDES; ADULT; AGED; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CRITICAL ILLNESS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OXAZOLIDINONES; TREATMENT OUTCOME;

EID: 80052262920     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.05.007     Document Type: Article

References (28)

1. J.A. Cortés, D.C. Garzón, J.A. Navarrete, and K.M. Contreras Impact of inappropriate antimicrobial therapy on patients with bacteremia in intensive care units and resistance patterns in Latin America Rev Argent Microbiol 42 2010 230 234
2. R. Maviglia, R. Nestorini, and M. Pennisi Role of old antibiotics in multidrug resistant bacterial infections Curr Drug Targets 10 2009 895 905
3. M. Leone, and C. Martin How to break the vicious circle of antibiotic resistances? Curr Opin Crit Care 14 2008 587 592
4. D.R. Ashtekar, R. Costa-Periera, T. Shrinivasan, R. Iyyer, N. Vishvanathan, and W. Rittel Oxazolidinones, a new class of synthetic antituberculosis agent. In vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis Diagn Microbiol Infect Dis 14 1991 465 471
5. G.M. Eliopoulos, C.B. Wennersten, H.S. Gold, and R.C. Moellering Jr. In vitro activities in new oxazolidinone antimicrobial agents against enterococci Antimicrob Agents Chemother 40 1996 1745 1747 (Pubitemid 26227372)
6. J.H. Jorgensen, M.L. McElmeel, and C.W. Trippy In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species Antimicrob Agents Chemother 41 1997 465 467 (Pubitemid 27111048)
7. G.A. Noskin, F. Siddiqui, V. Stosor, J. Kruzynski, and L.R. Peterson Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin Clin Infect Dis 28 1999 689 690 (Pubitemid 29242559)
8. P.W. Ament, N. Jamshed, J.P. Horne, and Linezolid: its role in the treatment of Gram-positive, drug-resistant bacterial infections Am Fam Physician 65 2002 663 670 (Pubitemid 34175040)
9. K.T. Bain, and E.T. Wittbrodt Linezolid for the treatment of resistant Gram-positive cocci Ann Pharmacother 35 2001 566 575 (Pubitemid 32428132)
10. O. Rodríguez, F. Alvarez, R. Oltra, E. Cereijo, M.M. Latorre, and H. Martínez Use of linezolid in critically ill patients admitted to intensive care units Rev Esp Quimioter 22 2009 68 75
11. S. Kelly, J. Collins, M. Maguire, C. Gowing, M. Flanagan, and M. Donnelly An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit J Antimicrob Chemother 61 2008 901 907 (Pubitemid 351426077)
12. K.K. Kinney Treatment of infections caused by antimicrobial-resistant Gram-positive bacteria Am J Med Sci 340 2010 209 217
13. M.J. Gentry-Nielsen, K.M. Olsen, and L.C. Preheim Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia Antimicrob Agents Chemother 46 2002 1345 1351 (Pubitemid 34415313)
14. A.M. Lovering, R. Le Floch, L. Hovsepian, J. Stephanazzi, P. Bret, and G. Birraux Pharmacokinetic evaluation of linezolid in patients with major thermal injuries J Antimicrob Chemother 63 2009 553 559
15. S. Swoboda, M.C. Ober, C. Lichtenstern, S. Saleh, V. Schwenger, and H.G. Sonntag Pharmacokinetics of linezolid in septic patients with and without extended dialysis Eur J Clin Pharmacol 66 2010 291 298
16. C.R. Rayner, A. Forrest, A.K. Meagher, M.C. Birmingham, and J.J. Schentag Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme Clin Pharmacokinet 42 2003 1411 1423 (Pubitemid 38054365)
17. D.J. Stalker, and G.L. Jungbluth Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial Clin Pharmacokinet 42 2003 1129 1140 (Pubitemid 37357649)
18. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
19. H. Dong, Y. Dong, X. Wang, H. Yang, and J. Liu Determination and clinical application of linezolid concentration in human serum by HPLC Yaowu Fenxi Zazhi (Chin J Pharmaceutic Anal) 30 2010 199 203
20. F. Pea, and M. Furlanut Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions Clin Pharmacokinet 40 2001 833 868 (Pubitemid 33095999)
21. E. Boselli, D. Breilh, T. Rimmelé, S. Djabarouti, J. Toutain, and D. Chassard Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia Crit Care Med 33 2005 1529 1533 (Pubitemid 40980608)
22. J.J. Schentag Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit Crit Care Med 29 4 Suppl. 2001 N100 N107
23. D. Honeybourne, C. Tobin, G. Jevons, J. Andrews, and R. Wise Intrapulmonary penetration of linezolid J Antimicrob Chemother 51 2003 1431 1434 (Pubitemid 36748935)
24. A.P. MacGowan Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections J Antimicrob Chemother 51 Suppl. 2 2003 ii17 ii25
25. C. Buerger, N. Plock, P. Dehghanyar, C. Joukhadar, and C. Kloft Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis Antimicrob Agents Chemother 50 2006 2455 2463 (Pubitemid 43993186)
26. C. Thallinger, C. Buerger, N. Plock, S. Kljucar, S. Wuenscher, and R. Sauermann Effect of severity of sepsis on tissue concentrations of linezolid J Antimicrob Chemother 61 2008 173 176
27. C. Adembri, S. Fallani, M.I. Cassetta, S. Arrigucci, A. Ottaviano, and P. Pecile Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion Int J Antimicrob Agents 31 2008 122 129
28. F. Pea, M. Furlanut, P. Cojutti, F. Cristini, E. Zamparini, and L. Franceschi Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis Antimicrob Agents Chemother 54 2010 4605 4610